Prospect Capital Corp Files 424B2 Prospectus

Ticker: PSEC · Form: 424B2 · Filed: 2026-04-06T16:02:30-04:00

Sentiment: neutral

Topics: prospectus, offering, securities

Related Tickers: PSEC

TL;DR

PROSP is selling more stock, check the prospectus for details.

AI Summary

Prospect Capital Corporation filed a 424B2 prospectus on April 6, 2026, detailing the offering of its common stock. The filing, with SEC Accession No. 0001287032-26-000127, provides information for investors regarding the sale of securities. The company's business address is 10 East 40th Street, 44th Floor, New York, NY 10016.

Why It Matters

This filing indicates Prospect Capital Corporation is actively engaging in the sale of its common stock, which could impact its share price and investor base.

Risk Assessment

Risk Level: low — This is a standard prospectus filing (424B2) which is routine for companies offering securities and does not inherently indicate new risks.

Key Numbers

Key Players & Entities

FAQ

What type of security is Prospect Capital Corp offering?

The filing is a 424B2 prospectus, which typically details the offering of common stock or other securities.

When was this prospectus filed?

The prospectus was filed on April 6, 2026.

What is the SEC Accession Number for this filing?

The SEC Accession Number is 0001287032-26-000127.

Where is Prospect Capital Corp located?

Prospect Capital Corp's business and mailing address is 10 East 40th Street, 44th Floor, New York, NY 10016.

What is the purpose of a 424B2 filing?

A 424B2 filing is a prospectus supplement used to provide additional information about securities being offered for sale, often after an initial registration statement has been filed.

Filing Stats: 4,533 words · 18 min read · ~15 pages · Grade level 14.7 · Accepted 2026-04-06 16:02:30

Key Financial Figures

Filing Documents

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS Our annual report on Form 10-K for the year ended June 30, 2025, any of our quarterly reports on Form 10-Q or current reports on Form 8-K, or any other oral or written statements made in press releases or otherwise by or on behalf of Prospect Capital Corporation including this prospectus supplement, the accompanying prospectus and any related free writing prospectus may contain forward-looking statements within the meaning of Section 21E of the Exchange Act which involve substantial risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and portfolio management and the performance of our investments and our investment management business. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about our industry, our beliefs, and our assumptions. Words such as "intends," "intend," "intended," "goal," "estimate," "estimates," "expects," "expect," "expected," "project," "projected," "projections," "plans," "seeks," "anticipates," "anticipated," "should," "could," "may," "will," "designed to," "foreseeable future," "believe," "believes," "continues" and "scheduled" and variations of these words and similar expressions are intended to identify forward-looking statements. Our actual results or outcomes may differ materially from those anticipated. Readers are cautioned not to place undue reliance on these forward looking statements, which speak only as of the date the statement was made. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements do not meet the safe harbor for forward-looking statements pursuant to Section 27A of the Securities Act of 1933 or the "Securities Act." These statements are not guarantees of future performance and are subject

Forward-Looking Statements

Forward-Looking Statements S- ii Prospectus Summary S- 1

Risk Factors

Risk Factors S- 7 Description of the Notes S- 15 Registration and Settlement S- 33 Supplement to Material U.S. Federal Income Tax Considerations S- 36 Certain Considerations Applicable to ERISA, Governmental and Other Plan Investors S- 41

Use of Proceeds

Use of Proceeds S- 43 Plan of Distribution S- 44 Legal Matters S- 46 Independent Registered Public Accounting Firm S- 46 Available Information S- 46 PROSPECTUS Page Incorporation By Reference ii About This Prospectus 1 Prospectus Summary 2 Fees and Expenses 8 Financial Highlights 11

Risk Factors

Risk Factors 12

Use of Proceeds

Use of Proceeds 13

Forward-Looking Statements

Forward-Looking Statements 14 Distributions 16 Senior Securities 17 Price Range of Common Stock 18 Management of the Company 19 Certain Relationships and Transactions 21 Control Persons and Principal Stockholders 22 Portfolio Companies 24 Sales of Common Stock Below Net Asset Value 45 Dividend Reinvestment and Direct Stock Purchase Plan 50 Material U.S. Federal Income Tax Considerations 52 Description of Our Capital Stock 59 Description of Our Preferred Stock 66 Description of Our Debt Securities 67 Description of Our Subscription Rights 78 Description of Our Warrants 79 Description of Our Units 80 Custodian, Transfer and Dividend Paying Agent and Registrar 81 Brokerage Allocation and Other Practices 82 Legal Matters 83 Independent Registered Public Accounting Firm 83 Available Information 83 S-iv PROSPECTUS SUMMARY This section summarizes the legal and financial terms of the notes that are described in more detail in "Description of Notes" beginning on page S-15. This summary is not complete and may not contain all of the information that you may want to consider before investing in the notes. Final terms of any particular notes will be determined at the time of sale and will be contained in the pricing supplement, which will be included with this prospectus supplement, relating to those notes. The terms in that pricing supplement may vary from and supersede the terms contained in this summary and in "Description of Notes." In addition, you should read the more detailed information appearing elsewhere in this prospectus supplement, the accompanying prospectus, in that pricing supplement, in any related free writing prospectus and in the documents incorporated by reference in this prospectus supplement and accompany prospectus, as provided in "Incorporation by Reference" beginning on page S-i of this prospectus supplement and page ii of the prospectus and in "Available Information" beginning on pag

View on Read The Filing